
Synergy Shield Coronary Stent 2.50 X 8 | REF H7493966608250
Boston Scientific Synergy Shield Coronary Stent, 2.50 mm x 8 mm (REF H7493966608250) for B2B medical device procurement.

The MicroPort Firehawk Rapamycin Target Eluting Coronary Stent System (REF RV3518) is a 3.50 mm × 18 mm drug-eluting coronary stent mounted on a rapid exchange delivery catheter. Firehawk uses a cobalt-chromium stent platform with abluminal grooves engineered to carry a targeted dose of sirolimus (rapamycin) in a biodegradable polymer, intended to support controlled drug release at the vessel wall during percutaneous coronary intervention (PCI).
Key Features
- Targeted abluminal drug delivery: Laser-cut grooves on the outer stent surface carry sirolimus in a biodegradable polymer, designed to direct drug elution toward the vessel wall.
- Cobalt-chromium platform: Thin-strut cobalt-chromium alloy scaffold engineered for deliverability, radial strength and conformability.
- Biodegradable polymer carrier: Polymer is designed to degrade after drug release, leaving a polymer-free stent surface over time.
- Rapid exchange (Rx) delivery system: Monorail catheter design intended for single-operator use over a 0.014" guidewire.
- Radiopaque markers: Catheter markers intended to aid fluoroscopic positioning of the stent within the target lesion.
- Size configuration: Nominal stent diameter 3.50 mm, nominal stent length 18 mm.
Clinical Applications
- Intended for use in percutaneous coronary intervention procedures involving native coronary artery lesions.
- Suitable case selection, vessel sizing and deployment pressures should follow the manufacturer's Instructions for Use and applicable local regulatory labeling.
- Use is restricted to trained interventional cardiology professionals in appropriately equipped catheterization facilities.
Product Information
Brand: MicroPort
Product family: Firehawk Rapamycin Target Eluting Coronary Stent System
Category: Coronary Stents / Drug-Eluting Stents
REF / UPN: RV3518
Nominal stent diameter: 3.50 mm
Nominal stent length: 18 mm
Stent material: Cobalt-chromium alloy
Active drug: Sirolimus (rapamycin)
Polymer carrier: Biodegradable polymer (abluminal grooves)
Delivery system: Rapid exchange (Rx) balloon catheter
Guidewire compatibility: 0.014" (per IFU)
Sterility: Supplied sterile, single-use (per IFU)
Drug dose, strut thickness, guide catheter compatibility, crossing profile, balloon nominal/RBP pressures and shelf life: Not specified in the located sources — refer to the current MicroPort Firehawk Instructions for Use and product specification sheet.
Regulatory status: Availability and approved indications vary by market; confirm registration in the destination country before procurement.
Tell us what product you need and share a few details.
We connect your request with the most relevant verified brands.
Relevant supplier options can respond with availability, documentation context, and quote details.
Practical answers for procurement teams reviewing this product page.
Include the exact product family, brand preference, REF/UPN code when available, required quantity, destination country, expected delivery timing and documentation expectations.
Yes. If alternatives are acceptable, mention equivalent brands, compatible models, size ranges and any non-negotiable requirements.
Related products are connected through structured catalog data such as brand, category, product family and country assignment.
No. This page supports sourcing and RFQ organization. Buyers must verify regulatory status, clinical suitability and procurement compliance independently.
Specific codes reduce ambiguity and help supplier teams identify product availability, packaging details and documentation faster.
Yes. The workflow is designed for hospitals, clinics, distributors, wholesalers, importers and procurement departments.
Yes. Products can be connected to multiple countries in the admin panel, and buyers can specify destination details in the RFQ form.
The request is stored with contact and procurement details so the sourcing conversation can be reviewed and followed up clearly.